Redhill Biopharma
RDHL
#10400
Rank
S$7.51 M
Marketcap
S$1.48
Share price
-2.95%
Change (1 day)
-82.91%
Change (1 year)

Market capitalization of Redhill Biopharma (RDHL)

Market cap: S$7.51 Million

As of December 2025 Redhill Biopharma has a market cap of S$7.51 Million. This makes Redhill Biopharma the world's 10400th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Redhill Biopharma from 2013 to 2025

End of year Market Cap

Year Marketcap Change
2025S$7.51 M-37.51%
2024S$12.02 M-68.3%
2023S$37.93 M121.15%
2022S$17.15 M-90.61%
2021S$0.18 B-54.64%
2020S$0.40 B39.6%
2019S$0.28 B34.19%
2018S$0.21 B47.08%
2017S$0.14 B-43.37%
2016S$0.25 B11.51%
2015S$0.23 B49.61%
2014S$0.15 B60.78%
2013S$96.27 M

End of Day market cap according to different sources

On Dec 24th, 2025 the market cap of Redhill Biopharma was reported to be:

S$5.06 Million
by Nasdaq info icon info icon
S$7.51 Million
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Sanofi
SNY
S$150.38 B 2,000,619.12%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
S$341.26 B 4,540,218.93%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
S$127.17 B 1,691,917.11%๐Ÿ‡ฌ๐Ÿ‡ง UK
Taro Pharmaceutical
TARO
S$2.07 B 27,477.90%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Teva Pharmaceutical Industries
TEVA
S$46.73 B 621,717.94%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel